Detalles de la búsqueda
1.
Deficiency of the sedoheptulose kinase (Shpk) does not alter the ability of hematopoietic stem cells to rescue cystinosis in the mouse model.
Mol Genet Metab
; 134(4): 309-316, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823997
2.
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer.
J Transl Med
; 18(1): 214, 2020 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32466781
3.
Post-irradiation morphoea of the breast: a case report and review of the literature.
Histopathology
; 72(2): 342-350, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29110314
4.
TRIF-IFN-I pathway in Helicobacter-induced gastric cancer in an accelerated murine disease model and patient biopsies.
iScience
; 27(4): 109457, 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558931
5.
Activation of the TRIF pathway and downstream targets results in the development of precancerous lesions during infection with Helicobacter.
bioRxiv
; 2023 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37333238
6.
Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.
Genome Med
; 11(1): 50, 2019 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31358023
7.
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.
Genome Med
; 11(1): 34, 2019 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31126321
8.
Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.
Cell Death Dis
; 9(2): 21, 2018 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29343814
9.
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.
JCI Insight
; 3(24)2018 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30568030
10.
ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.
Clin Cancer Res
; 24(11): 2517-2529, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29581135
11.
A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer.
Clin Cancer Res
; 23(1): 26-34, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27126994
12.
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67.
Clin Cancer Res
; 23(15): 4035-4045, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28270498
13.
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.
Cell Metab
; 26(4): 633-647.e7, 2017 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28978427
14.
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.
Sci Transl Med
; 9(402)2017 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28794284
15.
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.
Sci Transl Med
; 9(391)2017 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28539475
16.
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
PLoS One
; 11(6): e0157368, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27310713
17.
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.
Nat Commun
; 7: 10582, 2016 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26822383
18.
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.
Sci Transl Med
; 8(334): 334ra53, 2016 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27075627
19.
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
Clin Cancer Res
; 22(6): 1499-509, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26515496
20.
Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.
Cancer Res
; 75(2): 405-14, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25480943